WIN Consortium and Brown University announce the election of Prof. Wafik El-Deiry, Director, Legorreta Cancer Center, Associate Dean, Oncologic Sciences, Warren Alpert Medical School, Brown University as Chair of the WIN Consortium beginning December 17, 2023.
See news article here:
https://www.winconsortium.org/
Professor Liang Cheng is the Chief Editor of the newly published book, MOLECULAR SURGICAL PATHOLOGY from the Springer Nature Publishing. It is ranked No. 1 Best Book Seller in Oncology Category, No 4 in Pathology, No. 12 in Biology and Life Sciences from the Amazon.
The book is available at the following link: https://www.amazon.com/Molecular-Surgical-Pathology-Liang-Cheng/dp/3031351177
Call for Pilot Project Proposals
Submission Deadline: February 15, 2024
The Department of Pathology and Laboratory Medicine at the Warren Alpert Medical School of Brown University is calling for proposal for pilot projects. The objective is to stimulate translational research collaborations and provide funding support for clinical faculty in the Brown affiliated hospital systems. Funds are available to support 2-3 projects (maximum of $25,000 per project).
Eligibility:
Faculty with employment in the Pathology Department of a Brown Affiliated Hospital are required as the primary applicant (Lifespan, Care New England, or the VA Hospitals).
Must be a joint proposal involving Pathology faculty (campus or hospital based) and/or inter-institutional research. Proposals involving three department sites (Brown, CNE, VA or Lifespan) are strongly encouraged.
One of principal investigators must be at the rank of assistant or associate professor.
The applicants have not received the same Pilot award from previous year.
Application Format:
Two to three-page proposal including:
CV from both Co-PIs
Project Period: April 15, 2024 – April 15, 2025
Reporting Requirements: The pilot project awardees will provide a final progress report to the Committee by July 1, 2025.
Application Submission: Applications should be submitted by e-mail to Drs. Liang Cheng [email protected] or Geralyn Lambert-Messerlian [email protected]. The submission deadline is February 15, 2024.
Committee Members:
Liang Cheng, MD, MS (Co-Chair)
Geralyn Lambert-Messerlian, PhD, FAACC (Co-Chair)
Sean Lawler, PhD
M. Ruhul Quddus, MD
Robert W. Sobol, PhD
Dr. Ece Uzun has been awarded the designation of Fellow of AMIA, or FAMIA. This achievement signals to patients, employers, and colleagues that you are an expert in evidence-based informatics practice and engaged with a community of life-long learners who apply the latest advances in informatics to improve health and health care.
Dr. Uzun will be honored along with 84 FAMIA recipients for her contributions to informatics and AMIA at the AMIA 2024 Clinical Informatics Conference , May 21-23, 2024 where she will be formally inducted into the Fellowship of AMIA. Certificates will be presented at the induction.
Dr. Liang Cheng is the senior corresponding author of this recently published article “Spatial relationship of tertiary lymphoid structures and tumor‐associated neutrophils in bladder cancer and prognostic potential for anti‐PD‐L1 immunotherapy” in Cancer Communications (Journal Impact Factor, 16.2). Please see the full article at the following link.
https://onlinelibrary.wiley.com/doi/full/10.1002/cac2.12491
Dr. Jonathan Kurtis, Chair of the Department of Pathology and Laboratory Medicine, has been selected as a 2023 award recipient of the Falk Medical Research Trust Transformational Award. Bank of America Private Bank, serves as Trustee of the Falk Medical Research Trust Transformational Award. The Medical Foundation at Health Resources in Action, Boston, MA (The Medical Foundation) administers the Falk Medical Research Trust Transformational Award on behalf of Bank of America Private Bank. Dr Kurtis’ project will focus on the discovery and pre-clinical development of novel anti-malarial drugs.
Congratulations to Professor Liang Cheng and his team for the Virchows Archiv Prize for the Best Paper, announced by the European Society of Pathology on the final day (September 13, 2023) of the 35th European Congress of Pathology in Dublin, Ireland. Dr. Liang Cheng is the senior author of the paper entitled “T1 Bladder Carcinoma with Variant Histology: Pathological Features and Clinical Significance”.
Below is the link to the Article and the You Tube Video
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Diagnosis and treatment of Plasmodium falciparum infections are required for effective malaria control and are pre-requisites for malaria elimination efforts; hence we need to monitor emergence, evolution and spread of drug- and diagnostics-resistant parasites. We deep sequenced key drug-resistance mutations and 1,832 SNPs in the parasite genomes of 609 malaria cases collected during a diagnostic-resistance surveillance study in Ethiopia. Please see article below:
Bailey lab collaboration with UCSF and Uganda investigators to understand the evolving resistance in Africa to frontline antimalarial artemisinin resistance published in New England Journal of Medicine. Please see link below: